|
|
||||||||
The Journal of Immunology, Vol 154, Issue 2 825-831, Copyright © 1995 by American Association of Immunologists
ARTICLES |
SL Jiang, G Lozanski, D Samols and I Kushner
Department of Medicine, MetroHealth Medical Center, Cleveland, OH 44109.
Previous studies of murine serum amyloid A (SAA) regulation during inflammatory states or following exposure to macrophage-conditioned medium have raised the possibility that both post-transcriptional and transcriptional mechanisms participate in induction of this family of proteins. Since IL-6 and IL-1 have been shown to induce SAA in human hepatoma cell lines, we explored the possibility that these cytokines might induce human SAA through post-transcriptional as well as transcriptional mechanisms. In kinetic studies, we found that continuous exposure of Hep 3B cells to either IL-6 or IL-1 beta alone caused only minimal increases in SAA mRNA and marginal increases in transcription (as measured by nuclear runon). In contrast, the combination of these cytokines led to a 23-fold increase in transcription, maximal at 12 h, with continuing increase in mRNA, achieving levels more than 1,000-fold greater than baseline by 72 h. This massive disparity between increases in mRNA and in transcription rate strongly supports the participation of post-transcriptional mechanisms in SAA induction by (IL-6 + IL-1 beta), whereas the lag between peaks of transcription and mRNA abundance reflects a relatively slow degradation rate of SAA mRNA. As observed by other workers, mean size of SAA mRNA decreased progressively over the course of incubation. Simultaneous kinetic studies of complement factors B and C3, haptoglobin, and alpha-1 protease inhibitor revealed several different patterns of response to IL-6 and IL-1 beta.
This article has been cited by other articles:
![]() |
M. Jacobson, C. Fellstrom, R. Lindberg, P. Wallgren, and M. Jensen-Waern Experimental swine dysentery: comparison between infection models J. Med. Microbiol., April 1, 2004; 53(4): 273 - 280. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. Longley, D. M. Steel, and A. S. Whitehead Posttranscriptional Regulation of Acute Phase Serum Amyloid A2 Expression by the 5'- and 3'-Untranslated Regions of Its mRNA J. Immunol., October 15, 1999; 163(8): 4537 - 4545. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ray, H. Schatten, and B. K. Ray Activation of Sp1 and Its Functional Co-operation with Serum Amyloid A-activating Sequence Binding Factor in Synoviocyte Cells Trigger Synergistic Action of Interleukin-1 and Interleukin-6 in Serum Amyloid A Gene Expression J. Biol. Chem., February 12, 1999; 274(7): 4300 - 4308. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. K. Ray and A. Ray Induction of Serum Amyloid A (SAA) Gene by SAA-activating Sequence-binding Factor (SAF) in Monocyte/Macrophage Cells. EVIDENCE FOR A FUNCTIONAL SYNERGY BETWEEN SAF AND Sp1 J. Biol. Chem., November 14, 1997; 272(46): 28948 - 28953. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ren and W. S.-L. Liao Transcription Factor AP-2 Functions as a Repressor That Contributes to the Liver-specific Expression of Serum Amyloid A1 Gene J. Biol. Chem., May 18, 2001; 276(21): 17770 - 17778. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |